Covid-19: India pins hopes on four vaccine candidates
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The government is expecting two vaccines against Covid-19 Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin to be available by January and around four vaccines by the end of April.

Covaxin is expected to be approved for emergency use by the end of January or early February if the shots clear regulatory scrutiny while Covishield is likely to seek emergency approval in the next few days.

They are expecting that by April, there will be at least four vaccines in India. So, there should be enough vaccines available to cover the priority group by June-July. Pfizer has also applied in India and its application will be reviewed over the next few days.

The government is expecting around 40 crore doses of Covishield vaccine over five to six months from Serum Institute of India and is also conducting bridging studies for it in India. While the government will need around 60 crore doses to inoculate the targeted 30 crore priority population, it is likely to get adequate doses once Covaxin and Sputnik V are approved.

Source:
https://health.economictimes.indiatimes.com/news/pharma/india-pins-hopes-on-4-vaccines-to-inoculate-30-crore-by-july/79599985
Dr. T●●●●z H●●●●●●i and 2 other likes this
Like
Comment
Share